Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.36 |
| ▸ | HPGD | P15428 | 1/20 | 0.36 |
| ▸ | GAA | P10253 | 2/20 | 0.35 |
| ▸ | NCEH1 | Q6PIU2 | 9/20 | 0.33 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.33 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.33 |
| ▸ | MEN1 | O00255 | 1/20 | 0.33 |
| ▸ | MAPT | P10636 | 1/20 | 0.33 |
| ▸ | RAB9A | P51151 | 1/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.33 |
| ▸ | NOX1 | Q9Y5S8 | 1/20 | 0.33 |
| ▸ | LMNA | P02545 | 1/20 | 0.33 |
| ▸ | TAAR1 | Q96RJ0 | 1/20 | 0.32 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20436321 | 0.86 | ALDH1A1 (0.37) | ALDH1A1HPGDNCEH1KDM4EMEN1 | |
| SCHEMBL20436305 | 0.86 | ALDH1A1 (0.43) | ALDH1A1HPGDGAAKDM4EMEN1 | |
| SCHEMBL20441429 | 0.82 | ALDH1A1 (0.36) | ALDH1A1HPGDGAANCEH1KDM4E | |
| SCHEMBL20436316 | 0.78 | GAA (0.38) | ALDH1A1GAATDP1MEN1MAPT | |
| SCHEMBL4401959 | 0.78 | ALDH1A1 (0.54) | ALDH1A1HPGDGAAKDM4EMEN1 | |
| SCHEMBL4125057 | 0.78 | ALDH1A1 (0.47) | ALDH1A1HPGDGAANCEH1KDM4E | |
| SCHEMBL20436319 | 0.77 | POLB (0.46) | ALDH1A1GAAKDM4EMEN1MAPT | |
| SCHEMBL20436314 | 0.76 | ITGB1 (0.37) | ALDH1A1KDM4ETDP1MEN1MAPT | |
| SCHEMBL20436311 | 0.76 | ABCC9 (0.48) | ALDH1A1GAAKDM4EMEN1MAPT | |
| SCHEMBL10030205 | 0.73 | HPGD (0.42) | ALDH1A1HPGDKDM4EMEN1MAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11327060-B2 | Method for analyzing enantiomer | AJINOMOTO CO., INC. (JP) | 2022-05-10 | — | — | US | disclosed |
| EP-3358346-B1 | ENANTIOMER ANALYSIS METHOD | AJINOMOTO KK (JP) | 2022-01-19 | — | — | EP | disclosed |
| US-20180217113-A1 | METHOD FOR ANALYZING ENANTIOMER | AJINOMOTO CO., INC. (JP) | 2018-08-02 | — | — | US | disclosed |
| US-20180217113-A1 | METHOD FOR ANALYZING ENANTIOMER | AJINOMOTO CO., INC. (JP) | 2018-08-02 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11327060-B2 | Method for analyzing enantiomer | DCX, INF2, SRD5A2 | ALDH1A1 834/4885HPGD 1872/4885GAA 4303/4885 |
| US-20180217113-A1 | METHOD FOR ANALYZING ENANTIOMER | DCX, INF2, SRD5A2 | ALDH1A1 834/4885HPGD 1872/4885GAA 4303/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.